About
About
Management Team
Board of Directors
Ophthalmic Advisory Board
Optometry Advisory Board
Technology
Technology
Neutrox
Aganocides
Products
Products
Avenova
NeutroPhase
CelleRx
Partners
Partners
IHT
Pioneer Pharma
Principle Business Enterprises
Virbac
Investors
Investors
Events
Corporate Governance
Corporate Presentation
Composition of Board Committees
SEC Filings
Stock Information
News
News
Press Releases
Published Articles
Posters
Media
Contact
We’re Hiring
No menu assigned!
NovaBay Pharmaceuticals Reports Third Quarter 2009 Financial Results, Provides Pipeline Update
By
WEBDOGS
November 13, 2009
No Comments
0
0
0
Next Post
NovaBay’s Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis
NovaBay’s Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis
TOP
About
About
Management Team
Board of Directors
Ophthalmic Advisory Board
Optometry Advisory Board
Technology
Technology
Neutrox
Aganocides
Products
Products
Avenova
NeutroPhase
CelleRx
Partners
Partners
IHT
Pioneer Pharma
Principle Business Enterprises
Virbac
Investors
Investors
Events
Corporate Governance
Corporate Presentation
Composition of Board Committees
SEC Filings
Stock Information
News
News
Press Releases
Published Articles
Posters
Media
Contact
We’re Hiring
